PCVX
Price
$111.58
Change
-$0.52 (-0.46%)
Updated
Sep 6 closing price
58 days until earnings call
STRO
Price
$4.12
Change
-$0.17 (-3.96%)
Updated
Sep 6 closing price
61 days until earnings call
Ad is loading...

PCVX vs STRO

Header iconPCVX vs STRO Comparison
Open Charts PCVX vs STROBanner chart's image
Vaxcyte
Price$111.58
Change-$0.52 (-0.46%)
Volume$2.35M
CapitalizationN/A
Sutro Biopharma
Price$4.12
Change-$0.17 (-3.96%)
Volume$359.26K
CapitalizationN/A
View a ticker or compare two or three
PCVX vs STRO Comparison Chart
Loading...
PCVX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PCVX vs. STRO commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCVX is a Buy and STRO is a StrongSell.

COMPARISON
Comparison
Sep 08, 2024
Stock price -- (PCVX: $112.10 vs. STRO: $4.29)
Brand notoriety: PCVX and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PCVX: 572% vs. STRO: 60%
Market capitalization -- PCVX: $13.6B vs. STRO: $337.69M
PCVX [@Biotechnology] is valued at $13.6B. STRO’s [@Biotechnology] market capitalization is $337.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $584.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCVX’s FA Score shows that 0 FA rating(s) are green whileSTRO’s FA Score has 0 green FA rating(s).

  • PCVX’s FA Score: 0 green, 5 red.
  • STRO’s FA Score: 0 green, 5 red.
According to our system of comparison, STRO is a better buy in the long-term than PCVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCVX’s TA Score shows that 6 TA indicator(s) are bullish while STRO’s TA Score has 5 bullish TA indicator(s).

  • PCVX’s TA Score: 6 bullish, 4 bearish.
  • STRO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than STRO.

Price Growth

PCVX (@Biotechnology) experienced а +41.40% price change this week, while STRO (@Biotechnology) price change was -5.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.71%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was -3.87%.

Reported Earning Dates

PCVX is expected to report earnings on Nov 04, 2024.

STRO is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (-2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($13.6B) has a higher market cap than STRO($338M). PCVX YTD gains are higher at: 78.503 vs. STRO (0.000). STRO has higher annual earnings (EBITDA): -63.93M vs. PCVX (-501.98M). PCVX has more cash in the bank: 1.45B vs. STRO (426M). PCVX (25.6M) and STRO (26.5M) have identical debt. STRO has higher revenues than PCVX: STRO (169M) vs PCVX (0).
PCVXSTROPCVX / STRO
Capitalization13.6B338M4,024%
EBITDA-501.98M-63.93M785%
Gain YTD78.5030.000-
P/E RatioN/AN/A-
Revenue0169M-
Total Cash1.45B426M341%
Total Debt25.6M26.5M97%
FUNDAMENTALS RATINGS
STRO: Fundamental Ratings
STRO
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PCVXSTRO
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
82%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
PCVX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACAFX9.180.07
+0.77%
American Century International Value G
USAGX20.15N/A
N/A
Victory Precious Metals and Minerals
VSQRX17.32-0.02
-0.12%
Invesco MSCI World SRI Index R
FKUQX23.66-0.03
-0.13%
Franklin Utilities A
KCSSX13.59-0.11
-0.80%
Knights of Columbus Small Cap S

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with ORKA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+2.70%
ORKA - PCVX
61%
Loosely correlated
-13.15%
LOGC - PCVX
45%
Loosely correlated
+0.68%
PLX - PCVX
43%
Loosely correlated
+0.99%
RXRX - PCVX
42%
Loosely correlated
+1.15%
FOLD - PCVX
41%
Loosely correlated
+1.48%
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with STOK. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then STOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
+0.23%
STOK - STRO
46%
Loosely correlated
-2.19%
ALGS - STRO
44%
Loosely correlated
+1.70%
INZY - STRO
42%
Loosely correlated
-0.19%
NUVB - STRO
41%
Loosely correlated
-4.32%
AVIR - STRO
40%
Loosely correlated
N/A
More